Beaumont Hospitals Michigan start 24hour swine flu call center!


The suburban Detroit Hospital chain says its H1N1 Call Center will be staffed around the clock. It says some callers may get voice mail at peak times, but the calls will be returned.
Beaumont says the line is designed to give accurate information about flu symptoms and when and where to seek medical care. The center can be reached by calling 888-375-H1N1 (4161). Beaumont is also hosting a live Web chat on H1N1 flu on Wednesday, Nov. 18 from 2 – 3 p.m. Jedd Roe, M.D. chief of Emergency Medicine at Beaumont Hospital, Royal Oak, will be available to respond to questions through an online chat room.

Michigan Flu Updates

State health officials said Monday that 28 Michigan residents have died and 801 have been hospitalized for the flu since Sept. 1.


Young Children; a Second Dose of 2009 H1N1 Influenza Vaccine provides
Robust Immune Response.

November 2, 2009

Interim results that show that children nine years of age and younger have a significantly improved immune response when given a second 15-microgram dose of 2009 H1N1 influenza vaccine reports the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The clinical trial evaluated the immune response of children six months to 17 years of age who received two doses of either 15 or 30 micrograms of 2009 H1N1 influenza vaccine. One of the main findings from this study among children nine years old and younger* revealed that the second dose produce a robust immune response after eight to 10 days. These results are similar to those recently reported in clinical trials of healthy adults. Younger children generally had a less robust early response to the vaccine.

*Infants younger than 6 months of age are too young to get the 2009 H1N1 and seasonal flu vaccines.

One dose of the H1N1 vaccine is needed for those 10 years and older. For children 6 months through 9 years of age, 2 doses of the H1N1 vaccine will be required. The doses need to be at least three weeks apart to get the best immune response to the vaccine.

The new recommendation of the Advisory Committee on Immunization Practices (ACIP), which sets U.S. recommendations for all immunizations are:

Children nine years of age and younger should receive two 15-microgram doses of 2009 H1N1 vaccine, to achieve an immune response likely to protect from illness. The trial data also continue to support the recommendation that children ten years of age and older should receive only one 15-microgram dose of vaccine.

The interim results include data from all available samples from the 583 children enrolled into the trial. Early results, based on blood samples taken eight to 10 days following the first injection, showed that in the majority of children 10 years of age and older, a single 15-microgram dose of vaccine produced a strong immune response. In contrast, most of the younger children did not respond strongly to only one dose of either 15 or 30 micrograms of vaccine.

New data, obtained eight to 10 days after the second vaccine dose, are compared here with results obtained 21 days after the first vaccine dose:

  1. Among the youngest children (6 to 35 months), 100 percent had a robust immune response after the second 15-microgram dose compared with only 25 percent three weeks after the first dose.
  2. In children aged 3 through 9 years old, 94 percent had a robust response after the second 15-microgram dose compared with only 55 percent three weeks after the first dose.
  3. In general, the immune responses in children receiving two 15-microgram doses and those receiving two 30-microgram doses of vaccine were similar; suggesting that receipt of two 15 microgram doses is adequate to obtain a strong immune response.  

Additional information about the 2009 H1N1 influenza, vaccines and other diseases are available at the National Institute of Allergy and Infectious Diseases (NIAID)) website listed on